PRGO Q1 2022 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B+6.4% YoY

Gross Profit

$338M31.4% margin

Operating Income

$22M2.0% margin

Net Income

-$2M-0.2% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

-2.8%

Cash Flow

Operating Cash Flow

$79M

Free Cash Flow

$59M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10.4B

Total Liabilities

$5.3B

Stockholders' Equity

$5.1B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.0B	+6.4%
Gross Profit	$338M	$368M	-8.3%
Operating Income	$22M	$51M	-57.8%
Net Income	-$2M	$38M	-106.3%

Revenue Segments

Consumer Self-Care Americas

$710M66%

Consumer Self-Care International

$365M34%

Geographic Segments

UNITED STATES

$683M63%

Europe

$352M33%

Other Geographical Areas

$40M4%

IRELAND

$7M1%